What Is Selank?

What Selank is, in one paragraph

Selank is a synthetic peptide — a short chain of seven amino acids — designed in Russia as a medicine for anxiety. It was built by taking a small natural molecule from the human immune system, called tuftsin, and adding a short chemical “tail” to make it more stable in the body. The result is a compound that researchers describe as anxiety-reducing and mildly cognition-supporting, with the unusual selling point of calm without drowsiness. It is approved and prescribed in Russia. It has never been approved by the US Food and Drug Administration, which is the single most important fact for anyone in the US reading about it.

This page is the orientation layer for everything else on the site about Selank. It explains what the compound actually is, where it came from, what it’s claimed to do, and what its US status is right now. The deeper questions — whether the evidence holds up, what it costs, how anxiety responses play out, what the side-effect picture looks like, and what legal access routes exist — each have their own dedicated page, linked throughout.

Where Selank came from

Selank was developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences, working with a Russian pharmacology institute. The starting point was tuftsin, a naturally occurring four-amino-acid peptide that the body produces from antibodies (immunoglobulin G) and that helps activate parts of the immune system.

Tuftsin on its own breaks down very quickly in the body, which makes it useless as a practical medicine. The Russian team’s key move was to attach a small three-amino-acid extension (Pro-Gly-Pro) to one end of tuftsin. That extension did two things: it protected the molecule from being chewed up by enzymes so it lasted long enough to act, and it shifted the molecule’s main effect away from the immune system and toward the brain and nervous system. The resulting seven-amino-acid peptide is Selank (also written in the scientific literature as TP-7).

So Selank’s origin story is genuinely a little unusual: an immune-system molecule was deliberately reshaped into a brain-acting one. That heritage is why you’ll still see Selank described as having immune-modulating properties alongside its anti-anxiety ones.

Note: Russia approved Selank as a prescription anxiety medicine in 2009. “Approved in Russia” is not the same as “approved in the US.” Different countries have completely separate drug-approval systems, and a drug cleared in one is not automatically legal or vetted in another.

How it’s thought to work

Honest answer first: the mechanism isn’t fully nailed down, and most of the detailed work is preclinical (animal and lab studies) rather than large human trials. With that caveat, the research points to Selank acting on several systems at once rather than hitting a single switch:

• GABA system. GABA is the brain’s main calming/inhibitory signal. Studies suggest Selank influences GABA signaling indirectly — possibly by changing how genes related to neurotransmission are expressed, rather than by plugging directly into a receptor the way a benzodiazepine does. That indirect route is one proposed reason it calms without the heavy sedation or dependence of benzodiazepines.
• Enkephalins. Selank appears to slow the breakdown of enkephalins, the body’s own mood- and stress-regulating peptides, which may extend their effect.
• BDNF and other signals. Some work links Selank to brain-derived neurotrophic factor (BDNF), a protein involved in learning and neural health, which is often cited to explain the claimed cognitive (“nootropic”) side.
• Immune signaling. Reflecting its tuftsin origin, Selank also shows effects on immune messengers such as interleukin-6 in some studies.

The takeaway isn’t a tidy “Selank does X.” It’s that the compound seems to nudge several stress- and mood-related systems gently, which fits the “calm without knockout” profile people report — but the human evidence behind these mechanisms is thin, old, and mostly from a single research lineage. For an evidence-quality breakdown of what’s actually supported versus marketed, see our Selank benefits & uses page.

What it’s used for

In its Russian approval and in the published research, Selank’s two headline uses are:

1. Anxiety. This is the anchor. Selank was developed specifically as an anxiolytic and was studied in generalized anxiety disorder, where small Russian trials reported effects comparable to standard treatment but without sedation, cognitive fog, or dependence. We take that anchor claim seriously — and examine where it holds and where it doesn’t — on the dedicated Selank for anxiety page.
2. Cognition / nootropic use. Selank is also marketed for focus, mental clarity, and stress resilience. This sits on weaker evidence than the anxiety claim and leans heavily on the BDNF and animal-learning research.

Beyond those, you’ll see it promoted for mood support, immune support, and general “stress management.” Those are real research threads in places, but they’re early and shouldn’t be read as established benefits. The honest framing is: one reasonably-supported use (anxiety), one plausible-but-thinner use (cognition), and a tail of speculative claims.

A critical detail that gets lost in marketing: the studied and Russian-approved form of Selank is intranasal — a spray or drops. Much of what’s sold to US buyers on the gray market is an injectable version. That’s a different delivery form than the one with the evidence behind it, which matters when you read claims or “reviews.”

Its US legal status in 2026

This is where Selank gets genuinely complicated, and it’s worth getting right because a lot of online sources oversimplify it.

There is no FDA-approved Selank product. Nothing you can get in the US is an approved drug. That alone puts it outside normal prescription channels.

The compounding-pharmacy angle is where the limbo sits. In late 2023 the FDA placed a batch of peptides into “Category 2” of its interim 503A bulks list — effectively blocking compounding pharmacies from using them. In September 2024, Selank (along with a few others) was removed from Category 2, but for a procedural reason: the parties who had nominated it withdrew the nomination. Removal from Category 2 sounds like good news, but it does not mean Selank became legal to compound.

To be legally compounded, a peptide generally needs to be added to the 503A bulks list, which happens only after review by the FDA’s Pharmacy Compounding Advisory Committee (PCAC) and formal rulemaking. Selank has never been on the 503A bulks list, and — unlike the well-publicized 2026 batch of peptides (such as BPC-157, TB-500, MOTS-C, and Semax) scheduled for PCAC review on July 23–24, 2026 — Selank is not on any announced PCAC agenda. It wasn’t part of the April 2026 group of peptides removed from Category 2 either. In short, it has no resolution date.

The practical consequence: Selank is neither clearly prohibited nor clearly authorized. A prescriber can legally write for it (it’s not a controlled substance), but compounding pharmacies often decline to fill it because the bulks-list pathway is unresolved. That mismatch — willing prescriber, unwilling pharmacy — is the defining feature of Selank’s US situation right now. We unpack exactly how that plays out, and what (if any) legitimate routes exist, on How to get Selank in the US.

Note: This status is current as of June 2026 and the peptide regulatory landscape is moving fast. Treat anything you read about FDA peptide status — here or elsewhere — as a snapshot, and check the date.

For the bigger framework on how peptide legality works in the US generally, see Are peptides legal in the US?.

How people access it (and why caution matters)

Because there’s no approved product and the compounding pathway is stuck, the realistic US access picture is narrow:

• Some anxiety-focused, integrative, longevity, or peptide-telehealth clinics will evaluate a patient and write for Selank, then attempt to source it through a compounding pharmacy. Whether a pharmacy fills it is the bottleneck.
• Conventional primary-care doctors and psychiatrists generally won’t prescribe it and will steer patients toward FDA-approved anxiety treatments instead.
• A large share of what’s actually consumed in the US comes from research-only (“for research use only”) gray-market vials sold online. These are not quality-controlled medicines. Their real identity, purity, and concentration are unverified, and the injectable form commonly sold differs from the intranasal form that was studied.

We don’t provide sourcing instructions, and the genuine safety concern here is straightforward: a “standard” dose of an unverified product is still an unverified product. The single biggest red flag in this space is any seller or provider that lets you buy and self-administer with no real medical evaluation.

For what dosing decisions actually involve and why fixed internet protocols are unsafe, see our Selank dosage explainer; for the reported tolerability picture, see Selank side effects; and for what it realistically costs across routes, see Selank cost in the US.

The honest bottom line

Selank is a real, decades-old Russian anxiety medicine with a genuinely interesting design and a clean-tolerability reputation, built on a small body of mostly Russian, mostly older, mostly unreplicated research. In the US it is not approved, sits in a regulatory limbo with no clear path to legal compounding, and is mostly obtained as an unverified gray-market product in a form different from the one that was studied. If you’re researching it, treat the anxiety claim as the most credible part of the story, treat everything else as less settled, and treat the access situation as the real practical obstacle.